Literature DB >> 23144197

PML-RARα co-operates with Sox4 in acute myeloid leukemia development in mice.

Nader Omidvar1, Mei Lin Maunakea, Letetia Jones, Sabina Sevcikova, Bin Yin, Karen L Himmel, Thelma R Tennant, Michelle M Le Beau, David A Largaespada, Scott C Kogan.   

Abstract

Acute promyelocytic leukemia is characterized by a chromosomal translocation involving the retinoic acid receptor alpha gene. To identify co-operating pathways to leukemogenesis, we crossed MRP8-PML/RARA transgenic mice with BXH-2 mice which harbor an endogenous murine leukemia virus that causes acute myeloid leukemia. Approximately half of the leukemias that arose in this cross showed features of acute promyelocytic leukemia. We identified 22 proviral insertion sites in acute promyelocytic-like leukemias and focused our analysis on insertion at Sox4, a HMG box transcription factor. Using a transplant model, co-operation between PML-RARα and Sox4 was confirmed with increased penetrance and reduced latency of disease. Interestingly, karyotypic analysis revealed cytogenetic changes suggesting that the factors combined to initiate but not complete leukemic transformation. The cooperation between these transcription factors is consistent with the paradigm of multiple routes to the disease and reinforces the concept that transcription factor networks are important therapeutic targets in myeloid leukemias.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23144197      PMCID: PMC3659942          DOI: 10.3324/haematol.2011.057067

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  24 in total

1.  Sox4 cooperates with CREB in myeloid transformation.

Authors:  Salemiz Sandoval; Christina Kraus; Er-Chieh Cho; Michelle Cho; Juraj Bies; Elena Manara; Benedetta Accordi; Elliot M Landaw; Linda Wolff; Martina Pigazzi; Kathleen M Sakamoto
Journal:  Blood       Date:  2012-05-24       Impact factor: 22.113

2.  Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.

Authors:  Michelle M Le Beau; Elizabeth M Davis; Bhumi Patel; Vernon T Phan; Jastinder Sohal; Scott C Kogan
Journal:  Blood       Date:  2003-04-10       Impact factor: 22.113

3.  Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable.

Authors:  S C Kogan; S H Hong; D B Shultz; M L Privalsky; J M Bishop
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

4.  Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia.

Authors:  Michelle M Le Beau; Sheila Bitts; Elizabeth M Davis; Scott C Kogan
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

5.  Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice.

Authors:  H G Bedigian; D A Johnson; N A Jenkins; N G Copeland; R Evans
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

6.  Ecotropic murine leukemia virus DNA content of normal and lymphomatous tissues of BXH-2 recombinant inbred mice.

Authors:  N A Jenkins; N G Copeland; B A Taylor; H G Bedigian; B K Lee
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

7.  Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4.

Authors:  M W Schilham; M A Oosterwegel; P Moerer; J Ya; P A de Boer; M van de Wetering; S Verbeek; W H Lamers; A M Kruisbeek; A Cumano; H Clevers
Journal:  Nature       Date:  1996-04-25       Impact factor: 49.962

8.  DNA binding activity of recombinant SRY from normal males and XY females.

Authors:  V R Harley; D I Jackson; P J Hextall; J R Hawkins; G D Berkovitz; S Sockanathan; R Lovell-Badge; P N Goodfellow
Journal:  Science       Date:  1992-01-24       Impact factor: 47.728

9.  Sequence-specific interaction of the HMG box proteins TCF-1 and SRY occurs within the minor groove of a Watson-Crick double helix.

Authors:  M van de Wetering; H Clevers
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

10.  Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus.

Authors:  R G Hawley; A Z Fong; B F Burns; T S Hawley
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  10 in total

1.  Disruption of the PHRF1 Tumor Suppressor Network by PML-RARα Drives Acute Promyelocytic Leukemia Pathogenesis.

Authors:  Céline Prunier; Ming-Zhu Zhang; Santosh Kumar; Laurence Levy; Olivier Ferrigno; Guri Tzivion; Azeddine Atfi
Journal:  Cell Rep       Date:  2015-02-12       Impact factor: 9.423

2.  PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias.

Authors:  C Ronchini; A Brozzi; L Riva; L Luzi; A M Gruszka; G E M Melloni; E Scanziani; G Dharmalingam; M Mutarelli; V Belcastro; S Lavorgna; V Rossi; O Spinelli; A Biondi; A Rambaldi; F Lo-Coco; D di Bernardo; P G Pelicci
Journal:  Leukemia       Date:  2016-12-27       Impact factor: 11.528

3.  hsa_circ_0000218/hsa-miR-139-3p/SOX4 regulatory feedback circuit influences the proliferation and apoptosis of gastric cancer cells.

Authors:  Ganlin Xia; Anxin Wang; Liangxue Li
Journal:  Cytotechnology       Date:  2022-01-10       Impact factor: 2.058

4.  The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia.

Authors:  Haiqing Ma; Saradhi Mallampati; Yue Lu; Baohua Sun; Enze Wang; Xiaohong Leng; Yun Gong; Haifa Shen; C Cameron Yin; Dan Jones; Hesham M Amin; M James You; Patrick Zweidler-McKay; Yupo Ma; Hagop M Kantarjian; Ralph B Arlinghaus; Armand Glassman; Xiaoping Sun
Journal:  Haematologica       Date:  2014-07-04       Impact factor: 9.941

5.  Cellular intrinsic mechanism affecting the outcome of AML treated with Ara-C in a syngeneic mouse model.

Authors:  Wenjun Zhao; Lirong Wei; Dongming Tan; Guangsong Su; Yanwen Zheng; Chao He; Zhengwei J Mao; Timothy P Singleton; Bin Yin
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

6.  Sox4 links tumor suppression to accelerated aging in mice by modulating stem cell activation.

Authors:  Miguel Foronda; Paula Martínez; Stefan Schoeftner; Gonzalo Gómez-López; Ralph Schneider; Juana M Flores; David G Pisano; Maria A Blasco
Journal:  Cell Rep       Date:  2014-07-17       Impact factor: 9.423

7.  High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia.

Authors:  Lin Fu; Huaping Fu; Lei Zhou; Keman Xu; Yifan Pang; Kai Hu; Jing Wang; Lei Tian; Yuanyuan Liu; Jijun Wang; Hongmei Jing; Wenrong Huang; Xiaoyan Ke; Jinlong Shi
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379

8.  Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish.

Authors:  J-W Lu; M-S Hsieh; H-A Hou; C-Y Chen; H-F Tien; L-I Lin
Journal:  Blood Cancer J       Date:  2017-08-25       Impact factor: 11.037

9.  Endogenous and combination retinoids are active in myelomonocytic leukemias.

Authors:  Orsola Di Martino; Haixia Niu; Gayla Hadwiger; Heikki Kuusanmaki; Margaret A Ferris; Anh Vu; Jeremy Beales; Carl Wagner; María P Menéndez-Gutiérrez; Mercedes Ricote; Caroline Heckman; John S Welch
Journal:  Haematologica       Date:  2021-04-01       Impact factor: 9.941

10.  Detailed characterization of the transcriptome of single B cells in mantle cell lymphoma suggesting a potential use for SOX4.

Authors:  Simone Valentin Hansen; Marcus Høy Hansen; Oriane Cédile; Michael Boe Møller; Jacob Haaber; Niels Abildgaard; Charlotte Guldborg Nyvold
Journal:  Sci Rep       Date:  2021-09-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.